APA

MacLeod D. L., Nelson L. E., Shawar R. M., Lin B. B., Lockwood L. G., Dirk J. E., Miller G. H., Burns J. L. & Garber R. L. (20000427). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.

Chicago

MacLeod D L, Nelson L E, Shawar R M, Lin B B, Lockwood L G, Dirk J E, Miller G H, Burns J L and Garber R L. 20000427. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.

Harvard

MacLeod D. L., Nelson L. E., Shawar R. M., Lin B. B., Lockwood L. G., Dirk J. E., Miller G. H., Burns J. L. and Garber R. L. (20000427). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.

MLA

MacLeod D L, Nelson L E, Shawar R M, Lin B B, Lockwood L G, Dirk J E, Miller G H, Burns J L and Garber R L. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases. 20000427.